Trans-resveratrol self-nano-emulsifying drug delivery system (SNEDDS) with enhanced bioavailability potential: optimization, pharmacokinetics and in situ single … G Singh, RS Pai Drug delivery 22 (4), 522-530, 2015 | 135 | 2015 |
Solid Dispersion: Methods and Polymers to increase the solubility of poorly soluble drugs LA Nikghalb, G Singh, G Singh, KF Kahkeshan Journal of Applied Pharmaceutical Science 2 (10), 170-175, 2012 | 131 | 2012 |
Optimized PLGA nanoparticle platform for orally dosed trans-resveratrol with enhanced bioavailability potential G Singh, RS Pai Expert opinion on drug delivery 11 (5), 647-659, 2014 | 124 | 2014 |
Recent Advances of Resveratrol in Nanostructured Based Delivery Systems and in the Management of HIV/AIDS G Singh, RS Pai Journal of Controlled Release 194, 178-188, 2014 | 77 | 2014 |
Optimization of pellets containing solid dispersion prepared by extrusion/spheronization using central composite design and desirability function G Singh, RS Pai, VK Devi Journal of Young Pharmacists 4 (3), 146-156, 2012 | 72 | 2012 |
Response surface methodology and process optimization of sustained release pellets using Taguchi orthogonal array design and central composite design G Singh, RS Pai, VK Devi Journal of advanced pharmaceutical technology & research 3 (1), 30-40, 2012 | 62 | 2012 |
In‐vitro/in‐vivo characterization of trans‐resveratrol‐loaded nanoparticulate drug delivery system for oral administration G Singh, RS Pai Journal of Pharmacy and Pharmacology 66 (8), 1062–1076, 2014 | 55 | 2014 |
Development and validation of a HPLC method for the determination of trans-resveratrol in spiked human plasma G Singh, RS Pai, V Pandit Journal of advanced pharmaceutical technology & research 3 (2), 130-135, 2012 | 52 | 2012 |
Atazanavir-loaded Eudragit RL 100 nanoparticles to improve oral bioavailability: optimization and in vitro/in vivo appraisal G Singh, RS Pai Drug delivery 23 (2), 532-539, 2016 | 48 | 2016 |
Optimized self-nanoemulsifying drug delivery system of atazanavir with enhanced oral bioavailability: in vitro/in vivo characterization G Singh, RS Pai Expert opinion on drug delivery 11 (7), 1023-1032, 2014 | 43 | 2014 |
In vitro and in vivo performance of supersaturable self-nanoemulsifying system of trans-resveratrol G Singh, RS Pai Artificial cells, nanomedicine, and biotechnology 44 (2), 510-516, 2016 | 36 | 2016 |
Development and validation of the liquid chromatographic method for simultaneous estimation of metformin, pioglitazone, and glimepiride in pharmaceutical dosage forms V Pandit, RS Pai, G Singh, K Devi, S Narayana, S Suresh Pharmaceutical Methods 3 (1), 9-13, 2012 | 27 | 2012 |
Pharmacokinetics and in vivo biodistribution of optimized PLGA nanoparticulate drug delivery system for controlled release of emtricitabine G Singh, RS Pai Drug Delivery 21 (8), 627-635, 2014 | 22 | 2014 |
Optimization (central composite design) and validation of HPLC method for investigation of emtricitabine loaded poly (lactic-co-glycolic acid) nanoparticles: in vitro drug … G Singh, RS Pai The Scientific World Journal 2014, 2014 | 20 | 2014 |
A rapid reversed-phase HPLC method for analysis of trans-resveratrol in PLGA nanoparticulate formulation G Singh, RS Pai ISRN Chromatography 2014, 2014 | 19 | 2014 |
Dawn of antioxidants and immune modulators to stop HIV-progression and boost the immune system in HIV/AIDS patients: An updated comprehensive and critical review G Singh, RS Pai Pharmacological Reports 67 (3), 600-605, 2015 | 18 | 2015 |
In vivo pharmacokinetic applicability of a simple and validated HPLC method for orally administered trans-resveratrol loaded polymeric nanoparticles to rats G Singh, RS Pai, V Pandit Journal of pharmaceutical investigation 44, 69-78, 2014 | 18 | 2014 |
Nanocarrier-based interventions for the management of MDR/XDR-TB S Mustafa, RS Pai, G Singh, V Kusum Devi Journal of drug targeting 23 (4), 287-304, 2015 | 17 | 2015 |
Design and optimization of novel in situ gel of mercaptopurine for sustained drug delivery R Nagendra, RS Pai, G Singh Brazilian Journal of Pharmaceutical Sciences 50, 107-119, 2014 | 17 | 2014 |
Resveratrol: Nanocarrier-based delivery systems to enhance its therapeutic potential G Singh Nanomedicine 15 (29), 2801-2817, 2020 | 11 | 2020 |